Ann: Appendix 4C - Quarterly and Business Update, page-14

Super

Cheers for the reply.  I'd thought that as well, but the last statement in their ASCO poster is ... Patients who complete Day 56 will continue in long term maintenance with administration of IMU-131 on Day 98 then every 84days.

For whatever reason, it looks like they've decided on a schedule of long term dosing.  It isn't on the trial notes and is the first time I've seen it mentioned.  Lesley seems a good type, I wouldn't be surprised to see her acting in best interests of the patients once day 56 was over.  In this case, further dosing guarantees a strong immune response without relying on the patient's immune system to trigger in opposition to the cancer.

Me, I like the idea of further dosing. 

Cheers